San Francisco, CA, United States of America

Stefan Koenig

This inventor holds 9 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 6 EPO patents. Top assignees: Genentech, Inc., Sunovion Pharmaceuticals Inc., Hoffmann-La Roche Inc.. Active years: 2012-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stefan Koenig. Retrieved from https://idiyas.com/inventor/stefan-koenig-uokeggz2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 

% Patents Active = 55.6

 

 

Average Co-Inventor Count = 8.1

ph-index = 1

Forward Citations = 7(Granted Patents)


Location History:

  • Shrewsbury, MA (US) (2012 - 2018)
  • San Francisco, CA (US) (2019 - 2024)
  • South San Francisco, CA (US) (2021 - 2024)

Company Filing History:


Years Active: 2012-2024

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Stefan Koenig

Introduction

Stefan Koenig is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the synthesis of complex compounds. With a total of 9 patents to his name, his work has had a considerable impact on drug development and production processes.

Latest Patents

One of his latest patents involves the synthesis of a bis-mesylate salt of 4-amino-N-(1-((3-chloro-2-fluorophenyl)amino)-6-methylisoquinolin-5-yl)thieno[3,2-d]pyrimidine-7-carboxamide. This manufacturing process features several efficient key reactions, including a robust and scalable Pd-catalyzed carbonylation reaction. This reaction generates thienopyrimidine and a highly chemoselective Pt/V/C-catalyzed nitro group reduction to access the penultimate intermediate. The final amide coupling was accomplished using a mild and safe protocol, resulting in a compound with excellent yield, purity, and form stability on a multikilogram production scale.

Another significant patent pertains to methods of preparing a poloxamer for use in cell culture medium. This patent outlines the preparation of poloxamer and the development of cell culture media containing it. The methods described are essential for cell culturing and polypeptide production from cells.

Career Highlights

Stefan Koenig has worked with prominent companies in the pharmaceutical industry, including Genentech, Inc. and Hoffmann-La Roche Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research and development.

Collaborations

Throughout his career, Stefan has collaborated with talented individuals such as Stephan Bachmann and Ganesh Prasadh Vissvesvaran. These collaborations have further enhanced his innovative capabilities and expanded the scope of his work.

Conclusion

Stefan Koenig's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His innovative approaches to drug synthesis and cell culture methods continue to influence the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…